CDKN2A and basaloid squamous cell carcinoma: No significant difference was detected in p16 status between the poorly differentiated squamous cell (mean index 2% in all cases, 4/46 positive) and the basaloid squamous cell carcinomas (mean index 3% in all cases, 3/36 positive).